Our politicians and health technology institutions invite this comparison, and the obvious question, given that the latter consistently invokes opportunity cost to justify rejecting funding for innovative medicines. Opportunity cost is not just an economic consideration. It is a moral and ethical question when the powerful are preferenced over patients. …
Opportunity cost is a moral and ethical question when it involves travel, tickets, or treating sick children
December 11, 2025 Latest NewsBioPharmaComment
Latest Video
Georgia Forrest
New Stories
-
Australians turn to local pharmacies as frontline of everyday healthcare
March 13, 2026 - - Latest News -
Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer
March 13, 2026 - - Latest News -
The leadership challenge behind Australia’s medicine access gap
March 13, 2026 - - Latest News -
Australia has spent four decades having the wrong conversation about medicines access
March 13, 2026 - - Latest News -
‘An absolute medical miracle’ - MPs highlight progress and challenges at Cystic Fibrosis event
March 13, 2026 - - Latest News -
Australia’s top community pharmacists honoured at national awards
March 13, 2026 - - Latest News -
A new prostate cancer technology moves closer to global trials after strong early results
March 12, 2026 - - Australian Biotech